Skip to content

Study of the relationship between irritable bowel syndrome and small intestinal bacterial overgrowth.

Study of the relationship between irritable bowel syndrome and small intestinal bacterial overgrowth.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014420
Enrollment
Unknown
Registered
2018-01-12
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome and small intestinal bacterial overgrowth

Interventions

Sponsors

The Affiliated Third Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) male or female aged 16 ~ 75 years. 2) experimental group: the diagnosis of IBS Roman IV standard, a clear diagnosis of IBS patients; Control group: match the recruiting over the same age, sex and without any other diseases of the digestive tract symptoms and healthy volunteers; 3) no other serious disease, mental disorders, with normal communication ability; 4) signed informed consent, agreed to participate in the study.

Exclusion criteria

Exclusion criteria: 1) complicated with other serious heart, liver, kidney, respiratory, digestive, blood, endocrine system disease; 2) the combination of various acute infection, tumor and severe arrhythmia, spirit system disorders; 3) pregnancy or lactation; 4) application of antibiotics, acid suppression, lactulose, probiotics, or other drugs affecting gastrointestinal dynamic history in the 4 weeks.

Design outcomes

Primary

MeasureTime frame
The incidence of SIBO in IBS patients;

Secondary

MeasureTime frame
The influence of SIBO in IBS;Types and volume of intestinal flora;

Countries

China

Contacts

Public ContactChen Dongfong

The Affiliated Third Hospital of Army Medical University

chendf1981@126.com+86 19923257387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026